Delivery Order SPE2DB22D2206-SPE2DB25FEF81

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,980.13 firm fixed-price delivery order contract is for the supply of 4,563,356,570 units of Heparin Sodium 5,000 Unit/0.5 mL 0.5 mL. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.29 firm-fixed-price delivery order is for the supply of 4566150328 HEPARIN SOD 5,000 UNIT/0.5 ML 0.5ML medical products. The award has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,725.37 Firm Fixed Price Delivery Order is for the supply of 4,559,215,239 units of Heparin Sodium 5,000 unit/0.5 mL 0.5 mL vials, with a completion date of November 30, 2022. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,413.80 Firm Fixed Price Delivery Order is for the provision of 4,564,336,591 units of Heparin 2,000 unit/2 mL vials. This contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEPARIN 25,000 UNIT/250 ML-D5W 250ML, a prescription pharmaceutical product, with a ceiling value of $1,655.04 and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency awarded a $497.97 delivery order contract to Amerisourcebergen Drug Corp for the supply of 10,000 unit/10mL vials of heparin. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support the medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,336.54 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency Troop Support Medical awarded a $100,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10,000 unit/mL vials of heparin sodium. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA medical product supply vehicle and will...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred one dollars and forty-eight cents to Amerisourcebergen Drug Corporation for twenty-five thousand units of heparin in two hundred fifty milliliter bags of dextrose and water solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,451.94 firm fixed price delivery order is for the supply of HEPAGAM B VIALML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEF81
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,451.35 firm fixed price delivery order is for the supply of Heparin 25,000 unit/250 mL-D5W 250 mL medical products. The contract has an ultimate completion date of November 15, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of that broader IDC. No set-aside designation is mentioned, indicating this was an open competition.

Generated 2/13/25, 9:25 AM